Integra Lifesciences Holdings Corp (IART)
23.57
+0.57
(+2.48%)
USD |
NASDAQ |
Nov 22, 11:18
Integra Lifesciences Holdings Total Liabilities (Quarterly): 2.544B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.544B |
| June 30, 2024 | 2.540B |
| March 31, 2024 | 2.480B |
| December 31, 2023 | 2.194B |
| September 30, 2023 | 2.160B |
| June 30, 2023 | 2.094B |
| March 31, 2023 | 2.067B |
| December 31, 2022 | 2.085B |
| September 30, 2022 | 2.083B |
| June 30, 2022 | 2.092B |
| March 31, 2022 | 2.057B |
| December 31, 2021 | 2.098B |
| September 30, 2021 | 2.143B |
| June 30, 2021 | 2.138B |
| March 31, 2021 | 2.212B |
| December 31, 2020 | 2.100B |
| September 30, 2020 | 2.056B |
| June 30, 2020 | 2.043B |
| March 31, 2020 | 2.106B |
| December 31, 2019 | 1.887B |
| September 30, 2019 | 1.962B |
| June 30, 2019 | 1.869B |
| March 31, 2019 | 1.809B |
| December 31, 2018 | 1.732B |
| September 30, 2018 | 1.814B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.844B |
| March 31, 2018 | 2.249B |
| December 31, 2017 | 2.249B |
| September 30, 2017 | 1.505B |
| June 30, 2017 | 1.207B |
| March 31, 2017 | 1.197B |
| December 31, 2016 | 968.29M |
| September 30, 2016 | 1.004B |
| June 30, 2016 | 1.019B |
| March 31, 2016 | 1.054B |
| December 31, 2015 | 1.023B |
| September 30, 2015 | 1.098B |
| June 30, 2015 | 926.17M |
| March 31, 2015 | 862.71M |
| December 31, 2014 | 883.10M |
| September 30, 2014 | 859.76M |
| June 30, 2014 | 873.79M |
| March 31, 2014 | 876.72M |
| December 31, 2013 | 526.05M |
| September 30, 2013 | 684.60M |
| June 30, 2013 | 670.91M |
| March 31, 2013 | 646.60M |
| December 31, 2012 | 645.82M |
| September 30, 2012 | 658.80M |
| June 30, 2012 | 654.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.887B
Minimum
Dec 2019
2.544B
Maximum
Sep 2024
2.159B
Average
2.099B
Median
Total Liabilities (Quarterly) Benchmarks
| Boston Scientific Corp | 17.12B |
| Haemonetics Corp | 1.646B |
| ResMed Inc | 2.027B |
| Globus Medical Inc | 1.017B |
| Perspective Therapeutics Inc | 62.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.066B |
| Shareholders Equity (Quarterly) | 1.522B |
| Debt to Equity Ratio | 1.187 |
| Current Ratio | 1.205 |
| Net Debt Paydown Yield | -5.39% |